9. Assessment Tools
stroke, FM, Pain, pain
STROKE
The evaluation consisted of obtaining the participants’ biodemographic and clinical information, followed by the evaluation of the outcome variables immediately before the BTxA injection, as well as after one and four months.The following assessment tools will be used for this study:Demographic characterization by age, gender, origin, time of stroke, use of medications, and previous therapies.Visual Analog Scale (VAS): Pain is classified as no pain (0), mild (1–3.9), moderate (4–7.9), and severe (8–10). Pain was assessed with the limb at rest and during active and passive mobilization [Manual goniometry—consists of evaluating the range of motion of the shoulder in the frontal, vertical, horizontal, external, and internal rotation planes of patients in the sitting position. For the study, the ranges of external rotation and shoulder abduction, both active and passive, were considered [Modified Asworth Scale (MAS): MAS was applied to the same movements evaluated in the goniometry, in this study in the shoulder internal rotator group and shoulder adductors. Patients scored as 1+ were considered as 1 for calculation and statistical purposes.Characterization of pain: For this item, the McGill questionnaire will be used. In each subgroup, the first descriptor scores less than the last, and the descriptor of each subgroup is considered the most intense [Fugl-Meyer Test (FM): Motor assessment includes measurement of movement, coordination and reflex activity of the shoulder, elbow, wrist, hand, hip, knee, and ankle. This scale has a total of 100 points for normal motor function, where the maximum score for upper extremity is 66 [